Abstract:
Poly(ADP-ribose) polymerase-1 (PARP-1) is a DNA-binding protein, which is primarily activated by nicks in the DNA molecule. It regulates the activity of various enzymes, including itself, and those involved in the control of DNA metabolism. Upon binding to DNA breaks, activated PARP cleaves NAD + into nicotinamide and ADP-ribose and polymerizes the latter on nuclear acceptor proteins including histones, transcription factors, and PARP itself. Poly(ADP-ribosylation) contributes to DNA repair and to the maintenance of genomic stability. Evidence obtained with pharmacological PARP inhibitors of various structural classes, as well as animals lacking the PARP-1 enzyme indicate that PARP plays an important role in cerebral ischemia/reperfusion, stroke, neurotrauma, neuroinjury, and neurodegeneration. Overactivation of PARP consumes NAD + and ATP culminating in cell dysfunction and necrosis. PARP activation can also act as a signal that initiates cell death programs, for instance through apoptosis-inducing factor (AIF) translocation. PARP has also been shown to associate with and regulate the function of several transcription factors. Of special interest is the enhancement by PARP of nuclear factor (NF)-κB-mediated transcription, which plays a central role in the expression of inflammatory cytokines, chemokines, adhesion molecules, and inflammatory mediators. Via this mechanism, PARP is involved in the upregulation of numerous proinflammatory genes that play a pathogenetic role in the later stage of central nervous system (CNS) diseases. Here, we review the roles of PARP in DNA damage signaling and cell death and summarize the pathogenetic role of PARP in neuroinflammation and neuroinjury.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AIF:
-
apoptosis-inducing factor
- APP:
-
amyloid precursor protein
- CNS:
-
central nervous system
- EAE:
-
experimental allergic encephalomyelitis
- ICAM-1:
-
intercellular adhesion molecule-1
- IFN:
-
interferon
- IL:
-
interleukin
- iNOS:
-
inducible nitric oxide synthase
- MCAO:
-
middle cerebral artery occlusion
- MS:
-
multiple sclerosis
- NOS:
-
nitric oxide synthase
- PARG:
-
poly(ADP-ribose) glycohydrolase
- PARP:
-
poly(ADP-ribose) polymerase
- PARP −/− cells/mice:
-
cells/mice homozygous for disrupted poly(ADP-ribose) polymerase genes
- ROS:
-
reactive oxygen species
- SCI:
-
spinal cord injury
- TBI:
-
traumatic brain injury
- TNF-α:
-
tumor necrosis factor-α
References
Abdelkarim GE, Gertz K, Harms C, Katchanov J, Dirnagl U. et al. 2001. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke. Int J Mol Med 7: 255–260.
Affar el B, Shah RG, Dallaire AK, Castonguay V, Shah GM. 2002. Role of poly(ADP-ribose) polymerase in rapid intracellular acidification induced by alkylating DNA damage. Proc Natl Acad Sci USA 99: 245–250.
Aito H, Aalto KT, Raivio KO. 2004. Adenine nucleotide metabolism and cell fate after oxidant exposure of rat cortical neurons: Effects of inhibition of poly(ADP-ribose) polymerase. Brain Res 1013: 117–124.
Almeida A, Bolanos JP. 2001. A transient inhibition of mitochondrial ATP synthesis by nitric oxide synthase activation triggered apoptosis in primary cortical neurons. J Neurochem 77: 676–690.
Ame JC, Rolli V, Schreiber V, Niedergang C, Apiou F, et al. 1999. PARP-2, A novel mammalian DNA damage-dependent poly(ADP-ribose) polymerase. J Biol Chem 274: 17860–17868.
Andjelkovic AV, Pachter JS. 1998. Central nervous system endothelium in neuroinflammatory, neuroinfectious, and neurodegenerative disease. J Neurosci Res 51: 432–430.
Andreassen OA, Dedeoglu A, Friedlich A, Ferrante KL, Hughes D, et al. 2001. Effects of an inhibitor of poly(ADP-ribose) polymerase, desmethylselegiline, trientine, and lipoic acid in transgenic ALS mice. Exp Neurol 168: 419–424.
Ang BT, Yap E, Lim J, Tan WL, Ng PY, et al. 2003. Poly(ADP-ribose) polymerase expression in human traumatic brain injury J Neurosurg 99: 125–130.
Aoyama N, Katayama Y, Kawamata T, Maeda T, Mori T, et al. 2002. Effects of antioxidant, OPC-14117, on secondary cellular damage and behavioral deficits following cortical contusion in the rat. Brain Res 934: 117–124.
Ara J, Przedborski S, Naini AB, Jackson-Lewis V, Trifiletti RR, et al. 1998. Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Proc Natl Acad Sci USA 95: 7659–7663.
Ayoub IA, Maynard KI. 2002. Therapeutic window for nicotinamide following transient focal cerebral ischemia. Neuroreport 13: 213–216.
Ayoub IA, Lee EJ, Ogilvy CS, Beal MF, Maynard KI. 1999. Nicotinamide reduces infarction up to 2 h after the onset of permanent focal cerebral ischemia in Wistar rats. Neurosci Lett 259: 21–24.
Azbill RD, Mu X, Bruce Keller AJ, Mattson MP, Springer JE. 1997. Impaired mitochondrial function, oxidative stress, and altered antioxidant enzyme activities following traumatic spinal cord injury. Brain Res 765: 283–290.
Babcock A, Owens T. 2003. Chemokines in experimental autoimmune encephalomyelitis and multiple sclerosis. Adv Exp Med Biol 520: 120–132.
Baldwin SA, Broderick R, Osbourne D, Waeg G, Blades DA, et al. 1998. The presence of 4-hydroxynonenal/protein complex as an indicator of oxidative stress after experimental spinal cord contusion in a rat model. J Neurosurg 88 (5): 874–883.
Bao F, Liu D. 2002. Peroxynitrite generated in the rat spinal cord induces neuron death and neurological deficits. Neuroscience 115: 839–849.
Barc S, Page G, Barrier L, Piriou A, Fauconneau B. 2001. Impairment of the neuronal dopamine transporter activity in MPP(+)-treated rat was not prevented by treatments with nitric oxide synthase or poly(ADP-ribose) polymerase inhibitors. Neurosci Lett 314: 82–86.
Beal MF. 1998. Excitotoxicity and nitric oxide in Parkinson's disease pathogenesis. Ann Neurol 44: S110–S114.
Beneke S, Diefenbach J, Burkle A. 2004. Poly(ADP-ribosylation) inhibitors: Promising drug candidates for a wide variety of pathophysiologic conditions. Int J Cancer 111: 813–818.
Benko R, Pacher P, Vaslin A, Kollai M, Szabó C. 2004. Restoration of the endothelial function in the aortic rings of apolipoprotein E deficient mice by pharmacological inhibition of the nuclear enzyme poly(ADP-ribose) polymerase. Life Sci 75: 1255–1261.
Besson VC, Croci N, Plotkine M, Marchand-Verrecchia, C. 2003. Deleterious poly(ADP-ribose) polymerase-1 pathway activation in traumatic brain injury in rat. Brain Res 989: 58–66.
Besson VC, Zsengeller Z, Plotkine M, Szabó C, Marchand-Verrecchia C. 2005. Beneficial effects of PJ34 and INO-1001, two novel water-soluble poly(ADP-ribose) polymerase inhibitors, on the consequences of traumatic brain injury in rat. Brain Res 1041(2): 150–157.
Bettelli E, Nicholson LB. 2000. The role of cytokines in experimental autoimmune encephalomyelitis. Arch Immunol Ther Exp 48: 389–398.
Bhat NR, Zhang P, Lee JC, Hogan EL. 1998. Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-α gene expression in endotoxin-stimulated primary glial cultures. J Neurosci 18: 1633–1641.
Blum D, Torch S, Lambeng N, Nissou M, Benabid AL, et al. 2001. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine, and MPTP: Contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol 65: 135–172.
Broomhead C, Hudson L. 1985. Administration of adenosine-ribosyl transferase antagonist allows in vivo control of antidinitrophenyl response. Int Arch Allergy Appl Immunol 77: 358–363.
Burkart V, Wang ZQ, Radons J, Heller B, Herceg Z, et al. 1999. Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic β-cell destruction and diabetes development induced by streptozocin. Nat Med 5: 314–319.
Bürkle A. 2001. Physiology and pathophysiology of poly(ADP ribosylation). BioEssays 23: 795–806.
Cassarino DS, Fall CP, Swerdlow RH, Smith TS, Halvorsen EM, et al. 1997. Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease. Biochim Biophys Acta 1362: 77–86.
Chatzipanteli K, Garcia R, Marcillo AE, Loor KE, Kraydieh S, et al. 2002. Temporal and segmental distribution of constitutive and inducible nitric oxide synthases after traumatic spinal cord injury: Effect of aminoguanidine treatment. J Neurotrauma 19: 639–651.
Cherian L, Goodman JC, Robertson CS. 2000. Brain nitric oxide changes after controlled cortical impact injury in rats. J Neurophysiol 83: 2171–2178.
Chiang SK, Lam TT. 2000. Posttreatment at 12 or 18 h with 3-aminobenzamide ameliorates retinal ischemia–reperfusion damage. Invest Ophthalmol Vis Sci 41: 3210–3214.
Chiarugi A. 2002. Inhibitors of poly(ADP-ribose) polymerase-1 suppress transcriptional activation in lymphocytes and ameliorate autoimmune encephalomyelitis in rats. Br J Pharmacol 137: 761–770.
Chiarugi A, Moskowitz MA. 2003. Poly(ADP-ribose) polymerase-1 activity promotes NF-κB-driven transcription and microglial activation: Implication for neurodegenerative disorders. J Neurochem 85: 306–317.
Chiarugi A, Meli E, Calvani M, Picca R, Baronti R, et al. 2003. Novel isoquinoline-derived inhibitors of poly(ADP-ribose) polymerase-1: Pharmacological characterization and neuroprotective effects in an in vitro model of cerebral ischemia JPET. 305: 943–947.
Chikawa T, Ikata T, Katoh S, Hamada Y, Kogure K, et al. 2001. Preventive effects of lecithinized superoxide dismutase and methylprednisolone on spinal cord injury in rats: Transcriptional regulation of inflammatory and neurotrophic genes. J Neurotrauma 18: 93–103.
Chung YH, Joo KM, Lee YJ, Shin DH, Cha CI. 2004. Reactive astrocytes express PARP in the central nervous system of SOD(G93A) transgenic mice. Brain Res 1003: 199–204.
Colak A, Soy O, Uzun H, Aslan O, Barut S, et al. 2003. Neuroprotective effects of GYKI 52466 on experimental spinal cord injury in rats. J Neurosurg Spine 98: 275–281.
Cole KK, Perez-Polo JR. 2002. Poly(ADP-ribose) polymerase inhibition prevents both apoptotic-like delayed neuronal death and necrosis after H 2O 2 injury. J Neurochem 82: 19–29.
Colicos MA, Dash PK. 1996. Apoptotic morphology of dentate gyrus granule cells following experimental cortical impact injury in rats: Possible role in spatial memory deficits. Brain Res 739: 120–131.
Cookson MR, Ince PG, Shaw PJ. 1998. Peroxynitrite and hydrogen peroxide-induced cell death in the NSC34 neuroblastoma x spinal cord cell line: Role of poly(ADP-ribose) polymerase. J Neurochem 70: 501–508.
Cosi C, Colpaert F, Koek W, Degryse A, Marien M. 1996. Poly(ADP-ribose) polymerase inhibitors protect against MPTP-induced depletions of striatal dopamine and cortical noradrenaline in C57B1/6 Mice. Brain Res 729: 264–269.
Cosi C, Suzuki H, Milani D, Facci L, Menegazzi M, et al. 1994. Poly(ADP-ribose) polymerase: Early involvement in glutamate-induced neurotoxicity in cultured cerebellar granule cells. J Neurosci Res 39: 38–46.
Couturier JY, Ding-Zhou L, Croci N, Plotkine M, Margaill, I. 2003. 3-aminobenzamide reduces brain infarction and neutrophil infiltration after transient focal cerebral ischemia in mice. Exp Neurol 184: 973–980.
Cross AH, Manning PT, Keeling RM, Schmidt RE, Misko TP. 1998. Peroxynitrite formation within the central nervous system in active multiple sclerosis. J Neuroimmunol 88: 45–56.
Cross AH, Manning PT, Stern MK, Misko TP. 1997. Evidence for the production of peroxynitrite in inflammatory CNS demyelination. J Neuroimmunol 80: 121–130.
Cross AH, San M, Stern MK, Keeling MA, Salvemini D, et al. 2000. A catalyst of peroxynitrite decomposition inhibits murine experimental autoimmune encephalomyelitis. J Neuroimmunol 107: 21–28.
Cuzzocrea S, Thiemermann C, Salvemini D. 2004. Potential therapeutic effect of antioxidant therapy in shock and inflammation. Curr Med Chem 11: 1147–1162.
Cuzzocrea S, Zingarelli B, Gilad E, Hake P, Salzman AL, et al. 1998. Protective effects of 3-aminobenzamide, an inhibitor of poly(ADP-ribose) synthase in a carrageenan-induced model of local inflammation. Eur J Pharmacol 342: 67–76.
Czapski GA, Cakala M, Kopczuk D, Strosznajder JB. 2004. Effect of poly(ADP-ribose) polymerase inhibitors on oxidative stress-evoked hydroxyl radical level and macromolecules oxidation in cell-free system of rat brain cortex. Neurosci Lett 356: 45–48.
Davidovic L, Vodenicharov M, Affar EB, Poirier GG. 2001. Importance of poly(ADP-ribose) glycohydrolase in the control of poly(ADP-ribose) metabolism. Exp Cell Res 268: 7–13.
Dawson VL. 1995. Nitric oxide: Role in neurotoxicity. Clin Exp Pharmacol Physiol 22: 305–308.
De Keyser J, Sulter G, Luiten PG. 1999. Clinical trials with neuroprotective drugs in acute ischemic stroke: Are we doing the right thing? Trends Neurosci 22: 535–540.
De Murcia G, Schreiber V, Molinete M, Saulier B, Poch O, et al. 1994. Structure and function of poly(ADP-ribose) polymerase. Mol Cell Biochem 138: 15–24.
De Murcia Shall S. (Eds.) 2000. From DNA damage and stress signaling to cell death; poly(ADP-ribosylation) reactions. Oxford, England: Oxford University Press.
Dewar D, Yam P, McCulloch J. 1999. Axonal injury caused by focal cerebral ischemia in the rat. Eur J Pharmacol 375: 441–450.
Diaz-Ruiz A, Ibarra A, Perez-Severiano F, Guizar-Sahagun G, Grijalva I, et al. 2002. Constitutive and inducible nitric oxide synthase activities after spinal cord contusion in rats. Neurosci Lett 319: 129–132.
Didier M, Bursztajn S, Adamec E, Passani L, Nixon RA, et al. 1996. DNA strand breaks induced by sustained glutamate excitotoxicity in primary neuronal cultures. J Neurosci 16: 2238–2250.
Ding Y, Zhou Y, Lai Q, Li J, Gordon V, et al. 2001. Long-term neuroprotective effect of inhibiting poly(ADP-ribose) polymerase in rats with middle cerebral artery occlusion using a behavioral assessment. Brain Res 915: 210–217.
Drukrach B, Schepens E, Stoff JC, Langeveld CH, Van Muiswinkel FL. 1998. Astrocyte-enhanced neuronal survival is mediated by scavenging of extracellular reactive oxygen species. Free Radic Biol Med 25: 217–220.
Du L, Zhang X, Han YY, Burke NA, Kochanek PM, et al. 2003a. Intramitochondrial poly(ADP-ribosylation) contributes to NAD + depletion and cell death induced by oxidative stress. J Biol Chem 278: 18426–18433.
Du X, Matsumura T, Edelstein D, Rossetti L, Zsengeller Z, et al. 2003b. Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J Clin Invest 112: 1049–1057.
Ducrocq S, Benjelloun N, Plotkine M, Ben-Ari Y, Charriaut-Marlangue C. 2000. Poly(ADP-ribose) synthase inhibition reduces ischemic injury and inflammation in neonatal rat brain. J Neurochem 74: 2504–2511.
Dyker AG, Lees KR. 1998. Duration of neuroprotection treatment for ischemic stroke. Stroke 29: 535–542.
Ehrlich W, Huser H, Kroger H. 1995. Inhibition of the induction of collagenase by interleukin-1β in cultured rabbit synovial fibroblasts after treatment with the poly(ADP-ribose) polymerase inhibitor 3-aminobenzamide. Rheumatol Int 15: 171–172.
Eliasson MJ, Sampei K, Mandir AS, Hurn PD, Traystman RJ, et al. 1997. Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat Med 3: 1089–1095.
Endres M, Scott G, Namura S, Salzman AL, Huang PL, et al. 1998a. Role of peroxynitrite and neuronal nitric oxide synthase in the activation of poly(ADP-ribose) synthetase in a murine model of cerebral ischemia–reperfusion. Neurosci Lett 248: 41–44.
Endres M, Scott GS, Salzman AL, Kun E, Moskowitz MA, et al. 1998b. Protective effects of 5-iodo-6-amino-1,2-benzopyrone, an inhibitor of poly(ADP-ribose) synthetase, against peroxynitrite-induced glial damage and stroke development. Eur J Pharmacol 351: 377–382.
Endres M, Wang ZQ, Namura S, Waeber C, Moskowitz MA. 1997. Ischemic brain injury is mediated by the activation of poly(ADP-ribose) polymerase. J Cereb Blood Flow Metab 17: 1143–1151.
Fabian RH, DeWitt DS, Kent TA. 1998. The 21-aminosteroid U-74389G reduces cerebral superoxide anion concentration following fluid percussion injury of the brain. J Neurotrauma 15: 433–440.
Fagni L, Lafon-Cazal M, Rondouin G, Manzoni O, Lerner-Natoli M, et al. 1994. The role of free radicals in NMDA-dependent neurotoxicity. Prog Brain Res 103: 381–390.
Falsig J, Christiansen SH, Feuerhahn S, Burkle A, Oei SL, et al. 2004. Poly(ADP-ribose) glycohydrolase as a target for neuroprotective intervention: Assessment of currently available pharmacological tools. Eur J Pharmacol 497: 7–16.
Farooque M, Isaksson J, Olsson Y. 2001. Improved recovery after spinal cord injury in neuronal nitric oxide synthase-deficient mice but not in TNF-α-deficient mice. J Neurotrauma 18: 105–114.
Ferrante RJ, Hantraye P, Brouillet E, Beal MF. 1999. Increased nitrotyrosine immunoreactivity in substantia nigra neurons in MPTP-treated baboons is blocked by inhibition of neuronal nitric oxide synthase. Brain Res 823: 177–182.
Ferraris D, Ficco RP, Dain D, Ginski G, Lautar S, et al. 2003. Design and synthesis of poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors. Part 4: Biological evaluation of imidazobenzodiazepines as potent PARP-1 inhibitors for treatment of ischemic injuries. Bioorg Med Chem 11: 3695–3707.
Fischer M. (ed) 2001. Stroke Therapy, 2nd ed. Butterworth Heineman: Woburn, MA.
Flentjar NJ, Crack PJ, Boyd R, Malin M, de Haan JB, et al. 2002. Mice lacking glutathione peroxidase-1 activity show increased TUNEL staining and an accelerated inflammatory response in brain following a cold-induced injury. Exp Neurol 177: 9–20.
Garcia Soriano F, Virág L, Jagtap P, Szabó É, Mabley JG, et al. 2001. Diabetic endothelial dysfunction: The role of poly(ADP-ribose) polymerase activation. Nat Med 7: 108–113.
Genovese T, Mazzon E, Muia C, Patel NS, Threadgill MD, et al. 2004. Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways and secondary damage in experimental spinal cord trauma. J Pharmacol Exp Ther 313: 529–538
Giovanelli L, Cozzi A, Guarnieri I, Dolara P, Moroni F. 2002. Comet assay as a novel approach for studying DNA damage in focal cerebral ischemia: Differential effects of NMDA receptor antagonists and poly(ADP-ribose) polymerase inhibitors. J Cereb Blood Flow Metab 22: 697–704.
Giovannoni G, Heales SJ, Land JM, Thompson EJ. 1998. The potential role of nitric oxide in multiple sclerosis. Mult Scler 4: 212–216.
Goss JR, Taffe KM, Kochanek PM, Dekosky ST. 1997. The antioxidant enzymes glutathione peroxidase and catalase increase following traumatic brain injury in the rat. Exp Neurol 146: 291–294.
Goto S, Xue R, Sugo N, Sawada MKK, Poitras MF, et al. 2002. Poly(ADP-ribose) polymerase impairs early and long-term experimental stroke recovery. Stroke 33: 1101–1106.
Greer WL, Kaplan JG. 1986. Early nuclear events in lymphocyte proliferation. The role of DNA strand break repair and ADP ribosylation. Exp Cell Res 166: 399–415.
Grotta JC. 1994. The current status of neuronal protective therapy: Why have all neuronal protective drugs worked in animals but none so far in stroke patients? Cerebrovas Dis 4: 115–120.
Gu Y, Sarnecki C, Aldape RA, Livingston DJ, Su MS. 1995. Cleavage of poly(ADP-ribose) polymerase by interleukin-1β-converting enzyme and its homologs TX and Nedd-2. J Biol Chem 270: 18715–18718.
Gupta S, Kaul CL, Sharma SS. 2004. Neuroprotective effect of combination of poly(ADP-ribose) polymerase inhibitor and antioxidant in middle cerebral artery occlusion-induced focal ischemia in rats. Neurol Res 26: 103–107.
Ha HC. 2004. Defective transcription factor activation for proinflammatory gene expression in poly(ADP-ribose) polymerase 1-deficient glia. Proc Natl Acad Sci USA 101: 5087–5092.
Ha HC, Hester LD, Snyder SH. 2002. Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia. Proc Natl Acad Sci USA 99: 3270–3275.
Hagberg H, Wilson MA, Matsushita H, Zhu C, Lange M, et al. 2004. PARP-1 gene disruption in mice preferentially protects males from perinatal brain injury. J Neurochem 90: 1068–1075.
Hall ED, Kupina NC, Althaus JS. 1999. Peroxynitrite scavengers for the acute treatment of traumatic brain injury. Ann NY Acad Sci 890: 462–468.
Hall ED, Yonkers PA, McCall JM, Braughler JM. 1988. Effects of the 21-aminosteroid U74006F on experimental head injury in mice. J Neurosurg 68: 456–461.
Hamada Y, Ikata T, Katoh S, Tsuchiya K, Niwa M, et al. 1996. Roles of nitric oxide in compression injury of rat spinal cord. Free Radic Biol Med 20: 1–9.
Hamm RJ, Temple MD, Pike BR, Ellis EF. 1996. The effect of postinjury administration of polyethylene glycol-conjugated superoxide dismutase (pegorgotein, Dismutec) or lidocaine on behavioral function following fluid-percussion brain injury in rats. J Neurotrauma 13: 325–332.
Hammer B, Parker WDJ, Bennett JPJ. 1993. NMDA Receptors increase OH radicals in vivo by using nitric oxide synthase and protein kinase C. Neuroreport 5: 72–74.
Hasko G, Mabley JG, Nemeth ZH, Pacher P, Deitch EA, et al. 2002. Poly(ADP-ribose) polymerase is a regulator of chemokine production: Relevance for the pathogenesis of shock and inflammation. Mol Med 8: 283–289.
Hassa PO, Hottiger MO. 1999. A role of poly(ADP-ribose) polymerase in NF-κB transcriptional activation. Biol Chem 380: 953–959.
Hausladen A, Fridovich I. 1994. Superoxide and peroxynitrite inactivate aconitases, but nitric oxide does not. J Biol Chem 269: 29405–29408.
Herceg Z, Wang ZQ. 2001. Functions of poly(ADP-ribose) polymerase (PARP) in DNA repair, genomic integrity, and cell death. Mutat Res 477: 97–110.
Hiromatsu Y, Sato M, Yamada K, Nonaka K. 1992a. Nicotinamide and 3-aminobenzamide inhibit recombinant human interferon-γ-induced HLA-DR antigen expression, but not HLA-A, -B, -C antigen expression, on cultured human thyroid cells. Clin Endocrinol (Oxf) 36: 91–95.
Hiromatsu Y, Sato M, Yamada K, Nonaka K. 1992b. Inhibitory effects of nicotinamide on recombinant human interferon-γ-induced intercellular adhesion molecule-1 (ICAM-1) and HLA-DR antigen expression on cultured human endothelial cells. Immunol Lett 31: 35–39.
Hivert B, Cerruti C, Camu W. 1998. Hydrogen peroxide-induced motoneuron apoptosis is prevented by poly(ADP ribosyl) synthetase inhibitors. Neuroreport 9: 1835–1838.
Homburg S, Visochek L, Moran N, Dantzer F, Priel E, et al. 2000. A fast signal-induced activation of poly(ADP-ribose) polymerase: A novel downstream target of phospholipase C. J Cell Biol 150: 293–307.
Hong SJ, Dawson TM, Dawson VL. 2004. Nuclear and mitochondrial conversations in cell death: PARP-1 and AIF signaling. Trends Pharmacol Sci 25: 259–264.
Hooper DC, Bagasra O, Marini JC, Zborek A, Ohnishi ST, et al. 1997. Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite. Implications for the treatment of multiple sclerosis. Proc Natl Acad Sci USA 94: 2528–2533.
Hooper DC, Kean RB, Scott GS, Spitsin SV, Mikheeva T, et al. 2001. The CNS inflammatory response to neurotropic virus infection is peroxynitrite dependent. J Immunol 167: 3470–3477.
Hooper DC, Morimoto K, Bette M, Weihe M, Koprowski H, et al. 1998a. Collaboration of antibody and inflammation in the clearance of rabies virus from the CNS. J Virol 72: 3711–3719.
Hooper DC, Scott GS, Zborek A, Mikheeva T, Kean RB, et al. 2000. Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood–CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis. FASEB J 14: 691–698.
Hooper DC, Spitsin S, Kean RB, Champion JM, Dickson GM, et al. 1998b. Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci USA 95: 675–680.
Hortobagyi T, Gorlach C, Benyo Z, Lacza Z, Hortobagyi S, et al. 2003. Inhibition of neuronal nitric oxide synthase-mediated activation of poly(ADP-ribose) polymerase in traumatic brain injury: Neuroprotection by 3-aminobenzamide. Neuroscience 121: 983–990.
Huang F, Vemuri MC, Schneider JS. 2004. Modulation of ATP levels alters the mode of hydrogen peroxide-induced cell death in primary cortical cultures: Effects of putative neuroprotective agents. Brain Res 997: 79–88.
Hung HC, Lee EH. 1998. MPTP produces differential oxidative stress and antioxidative responses in the nigrostriatal and mesolimbic dopaminergic pathways. Free Radic Biol Med 24: 76–84.
Hung TH, Skepper JN, Charnock-Jones DS, Burton GJ. 2002. Hypoxia-reoxygenation: A potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia. Circ Res 90: 1274–1281.
Hurn PD, Macrae IM. 2000. Estrogen as a neuroprotectant in stroke. J Cereb Blood Flow Metab 20: 631–652.
Irazuzta JE, Mirkin LD, Zingarelli B. 2000. Mercaptoethylguanidine attenuates inflammation in bacterial meningitis in rabbits. Life Sci 67: 365–372.
Iwashita A, Mihara K, Yamazaki S, Matsuura S, Ishida J, et al. 2004c. A new poly(ADP-ribose) polymerase inhibitor, FR261529 [2-(4-chlorophenyl)-5-quinoxalinecarboxamide], ameliorates methamphetamine-induced dopaminergic neurotoxicity in mice. J Pharmacol Exp Ther 310: 1114–1124.
Iwashita A, Tojo N, Matsuura S, Yamazaki S, Kamijo K, et al. 2004a. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-Chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia. J Pharmacol Exp Ther 310: 425–436.
Iwashita A, Yamazaki S, Mihara K, Hattori K, Yamamoto H, et al. 2004b. Neuroprotective effects of a novel poly(ADP-ribose) polymerase-1 inhibitor, 2-[3-[4-(4-chlorophenyl)-1-piperazinyl] propyl]-4(3H)-quinazolinone (FR255595), in an in vitro model of cell death and in mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. J Pharmacol Exp Ther 309: 1067–1078.
Jagtap P, Soriano FG, Virág L, Liaudet L, Mabley J, et al. 2002. Novel phenanthridinone inhibitors of poly(adenosine 5′-diphosphate-ribose) synthetase: Potent cytoprotective and antishock agents. Crit Care Med 30: 1071–1082.
Kabra DG, Thiyagarajan M, Kaul CL, Sharma SS. 2004. Neuroprotective effect of 4-amino-1,8-naphthalimide, a poly(ADP-ribose) polymerase inhibitor in middle cerebral artery occlusion-induced focal cerebral ischemia in rat. Brain Res Bull 62: 425–433.
Kamencic H, Griebel RW, Lyon AW, Paterson PG, Juurlink BH. 2001. Promoting glutathione synthesis after spinal cord trauma decreases secondary damage and promotes retention of function. FASEB J 15: 243–250.
Kameoka M, Ota K, Tetsuka T, Tanaka Y, Itaya A, et al. 2000. Evidence for the regulation of NF-κB by poly(ADP-ribose) polymerase. Biochem J 346: 641–649.
Kaminski SG, Hansson O, Ferrando-May E, Nicotera P, Brundin P, et al. 1999. Neuronal death in nigral grafts in the absence of poly(ADP-ribose) polymerase activation. Neuroreport 10: 3347–3351.
Karpus WJ, Fife BT, Kennedy KJ. 2003. Immunoneutralization of chemokines for the prevention and treatment of central nervous system autoimmune disease. Methods 29: 362–368.
Kastenbauer S, Koedel U, Becker BF, Pfister HW. 2001. Experimental meningitis in the rat: Protection by uric acid at human physiological blood concentrations. Eur J Pharmacol 425: 149–152.
Kastenbauer S, Koedel U, Becker BF, Pfister HW. 2002. Pneumococcal meningitis in the rat: Evaluation of peroxynitrite scavengers for adjunctive therapy. Eur J Pharmacol 449: 177–181.
Kastenbauer S, Koedel U, Pfister HW. 1999. Role of peroxynitrite as a mediator of pathophysiological alterations in experimental pneumococcal meningitis. J Infect Dis 180: 1164–1170.
Kaul M, Garden GA, Lipton SA. 2001. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410: 988–994.
Kean RB, Spitsin SV, Mikhaeva T, Scott GS, Hooper DC. 2000. The peroxynitrite scavenger uric acid prevents inflammatory cell invasion into the CNS in experimental allergic encephalomyelitis through maintenance of blood–CNS barrier integrity. J Immunol 165: 6511–6518.
Kim SH, Engelhardt JI, Henkel JS, Siklos L, Soos J, et al. 2004. Widespread increased expression of the DNA repair enzyme PARP in brain in ALS. Neurology 62: 319–322.
Kim SH, Henkel JS, Beers DR, Sengun IS, Simpson EP, et al. 2003. PARP expression is increased in astrocytes but decreased in motor neurons in the spinal cord of sporadic ALS patients. J Neuropathol Exp Neurol 62: 88–103.
King SL, McNerney R, Whitley GS, Johnstone AP. 1989. Differential role for ADP-ribosylation in gene expression during the activation of T lymphocytes by various stimuli. Immunology 67: 258–262.
Klaidman L, Morales M, Kem SS, Yang J, Chang ML, et al. 2003. Nicotinamide offers multiple protective mechanisms in stroke as a precursor for NAD, as a PARP inhibitor, and by partial restoration of mitochondrial function. Pharmacology 69: 150–157.
Klaidman LK, Mukherjee SK, Adams JDJ. 2001. Oxidative changes in brain pyridine nucleotides and neuroprotection using nicotinamide. Biochim Biophys Acta 1525: 136–148.
Klaidman LK, Mukherjee SK, Hutchin TP, Adams JD. 1996. Nicotinamide as a precursor for NAD + prevents apoptosis in the mouse brain induced by tertiary-butylhydroperoxide. Neurosci Lett 206: 5–8.
Koedel U, Pfister HW. 1999. Oxidative stress in bacterial meningitis. Brain Pathol 9: 57–67.
Koedel U, Bayerlein I, Paul R, Sporer B, Pfister HW. 2000. Pharmacologic interference with NF-κB activation attenuates central nervous system complications in experimental Pneumococcal meningitis. J Infect Dis 182: 1437–1445.
Koedel U, Winkler F, Angele B, Fontana A, Pfister HW. 2002. Meningitis-associated central nervous system complications are mediated by the activation of poly(ADP-ribose) polymerase. J Cereb Blood Flow Metab 22: 39–49.
Koh SH, Park Y, Song CW, Kim JG, Kim K, et al. 2004. The effect of PARP inhibitor on ischemic cell death, its related inflammation, and survival signals. Eur J Neurosci 20: 1461–1472.
Koistinaho M, Koistinaho J. 2002. Role of p38 and p44/42 mitogen-activated protein kinases in microglia. Glia 40: 175–183.
Koistinaho M, Kettunen MI, Goldsteins G, Keinänen R, Salminen A, et al. 2002. β-Amyloid precursor protein transgenic mice that harbor diffuse A β deposits but do not form plaques show increased ischemic vulnerability: Role of inflammation. Proc Natl Acad Sci USA 9: 1610–1615.
Komjáti K, Mabley JG, Virag L, Southan GJ, Salzman AL, et al. 2004. Poly(ADP-ribose) polymerase inhibition protects neurons and the white matter and regulates the translocation of apoptosis-inducing factor in stroke. Int J Mol Med 13: 373–382.
Kraus WL, Lis JT. 2003. PARP goes transcription. Cell 113: 677–683.
Kruman II, Culmsee C, Chan SL, Kruman Y, Guo Z, et al. 2000. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci 20: 6920–6926.
Lacza Z, Horvath EM, Komjati K, Hortobagyi T, Szabó C, et al. 2003. PARP inhibition improves the effectiveness of neural stem cell transplantation in experimental brain trauma. Int J Mol Med 12: 153–159.
Lafon-Cazal M, Culcasi M, Gaven F, Pietri S, Bockaert J. 1993. Nitric oxide, superoxide, and peroxynitrite: Putative mediators of NMDA-induced cell death in cerebellar granule cells. Neuropharmacology 32: 1259–1266.
Lam TT. 1997. The effect of 3-aminobenzamide, an inhibitor of poly(ADP-ribose) polymerase, on ischemia/reperfusion damage in rat retina. Res Commun Mol Pathol Pharmacol 95: 241–252.
LaPlaca MC, Raghupathi R, Verma A, Pieper AA, Saatman KE, et al. 1999. Temporal patterns of poly(ADP-ribose) polymerase activation in the cortex following experimental brain injury in the rat. Neurochemistry 73: 205–213.
LaPlaca MC, Zhang J, Raghupathi R, Li JH, Smith F, et al. 2001. Pharmacologic inhibition of poly(ADP-ribose) polymerase is neuroprotective following traumatic brain injury in rats. J Neurotrauma 18: 369–376.
Lautier D, Lageux J, Thibodeau J, Ménard L, Poirier GG. 1993. Molecular and biochemical features of poly(ADP-ribose) metabolism. Mol Cell Biochem 122: 171–193.
Le Page C, Sanceau J, Drapier J-C, Wietzerbin J, 1998. Inhibitors of ADP-ribosylation impair inducible nitric oxide synthase gene transcription through inhibition of NF-κB activation. Biochem Biophys Res Commun 243: 451–457.
Le Rhun Y, Kirkland JB, Shah GM. 1998. Cellular responses to DNA damage in the absence of poly(ADP-ribose) polymerase. Biochem Biophys Res Commun 245: 1–10.
Lee YS, Sindhu RK, Lin CY, Ehdaie A, Lin VW. 2004. Effects of nerve graft on nitric oxide synthase, NAD(P)H oxidase, and antioxidant enzymes in chronic spinal cord injury Free Radic Biol Med 36: 330–339.
Lee YW, Ha MS, Kim YK. 2001. H 2O 2-induced cell death in human glioma cells: Role of lipid peroxidation and PARP activation. Neurochem Res 26: 337–343.
Lees KR. 2002. Prospect for improved neuroprotection trials in stroke. Cerebrovascular Disease, 22nd Princeton Conference. Pak Chan, editor. Cambridge: Cambridge University Press; pp. 430–443.
Leski ML, Bao F, Wu L, Qian H, Sun D, et al. 2001. Protein and DNA oxidation in spinal injury: Neurofilaments—an oxidation target. Free Radic Biol Med 30: 613–624.
Lewen A, Skoglosa Y, Clausen F, Marklund N, Chan PH, et al. 2001. Paradoxical increase in neuronal DNA fragmentation after neuroprotective free radical scavenger treatment in experimental traumatic brain injury J Cereb Blood Flow Metab 21: 344–350.
Li F, Szabó C, Pacher P, Southan GJ, Abatan OI, et al. 2004. Evaluation of orally active poly(ADP-ribose) polymerase inhibitor in streptozotocin-diabetic rat model of early peripheral neuropathy. Diabetologia 47: 710–717.
Liaudet L, Soriano FG, Szabó E, Virag L, Mabley JG, et al. 2000. Protection against hemorrhagic shock in mice genetically deficient in poly(ADP-ribose) polymerase. Proc Natl Acad Sci USA 97: 10203–10208.
Liberatore GT, Jackson-Lewis V, Vukosavic S, Mandir AS, Vila M, et al. 1999. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Nat Med 5: 1403–1409.
Lin SH, Vincent A, Shaw T, Maynard KI, Maiese K. 2000. Prevention of nitric oxide-induced neuronal injury through the modulation of independent pathways of programmed cell death. J Cereb Blood Flow Metab 20: 1380–1391.
Liu C, Jin A, Zhou C, Chen B. 2002. Nitric oxide synthase gene expression in injured spinal cord tissue. Chin Med J (Engl) 115: 740–742.
Liu D, Ling X, Wen J, Liu J. 2000. The role of reactive nitrogen species in secondary spinal cord injury: Formation of nitric oxide, peroxynitrite, and nitrated protein. J Neurochem 75(5): 2144–2154.
Liu D, Liu J, Wen J. 1999. Elevation of hydrogen peroxide after spinal cord injury detected by using the Fenton reaction. Free Radic Biol Med 27: 478–482.
Liu D, Sybert TE, Qian H, Liu J. 1998. Superoxide production after spinal injury detected by microperfusion of cytochrome c. Free Radic Biol Med 25: 298–304.
Lo EH, Bosque-Hamilton P, Meng W. 1998. Inhibition of poly(ADP-ribose) polymerase: Reduction of ischemic injury and attenuation of N-methyl-d-aspartate-induced neurotransmitter dysregulation. Stroke 29: 830–836.
Lu XC, Massuda E, Lin Q, Li W, Li JH, et al. 2003. Posttreatment with a novel PARG inhibitor reduces infarct in cerebral ischemia in the rat. Brain Res 978: 99–103.
Lund FE, Cockayne DA, Randall TD, Solvason N, Schuber F, et al. 1998. CD38: a new paradigm in lymphocyte activation and signal transduction. Immunol Rev 161: 79–93.
Luo J, Shi R. 2004. Diffusive oxidative stress following acute spinal cord injury in guinea pigs and its inhibition by polyethylene glycol. Neurosci Lett 359: 167–170.
Mabley JG, Jagtap P, Perretti M, Getting SJ, Salzman AL, et al. 2001. Antiinflammatory effects of a novel, potent inhibitor of poly(ADP-ribose) polymerase. Inflamm Res 50: 561–569.
Mandir AS, Poitras MF, Berliner AR, Herring WJ, Guastella DB, et al. 2000. NMDA but not nonNMDA excitotoxicity is mediated by poly(ADP-ribose) polymerase. J Neurosci 20: 8005–8011.
Mandir AS, Przedborski S, Jackson-Lewis V, Wang ZQ, Simbulan-Rosenthal CM, et al. 1999. Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism. Proc Natl Acad Sci USA 96: 5774–5779.
Mao J, Price DD, Zhu J, Lu J, Mayer DJ. 1997. The inhibition of nitric oxide-activated poly(ADP-ribose) synthetase attenuates transsynaptic alteration of spinal cord dorsal horn neurons and neuropathic pain in the rat. Pain 72: 355–366.
Marklund N, Clausen F, McIntosh TK, Hillered L. 2001. Free radical scavenger posttreatment improves functional and morphological outcome after fluid percussion injury in the rat. J Neurotrauma 18: 821–832.
Martinet W, Knaapen MW, De Meyer GR, Herman AG, Kockx MM. 2002. Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation 106: 927–932.
Masutani M, Nozaki T, Nakamoto K, Nakagama H, Suzuki H, et al. 2000. The response of PARP knockout mice against DNA damaging agents. Mutat Res 462: 159–166.
Matthews RT, Beal MF, Fallon J, Fedorchak K, Huang PL, et al. 1997a. MPP +-induced substantia nigra degeneration is attenuated in nNOS knockout mice. Neurobiol Dis 4: 114–121.
Matthews RT, Yang L, Beal MF. 1997b. S-Methylthiocitrulline, a neuronal nitric oxide synthase inhibitor, protects against malonate and MPTP neurotoxicity. Exp Neurol 143: 282–286.
Maynard KI. 2002. Natural neuroprotectants after stroke. Sci Med Sept/Oct: 260–269.
Mazzon E, Serraino I, Li JH, Dugo L, Caputi AP, et al. 2001. GPI 6150, a poly(ADP-ribose) polymerase inhibitor, exhibits an antiinflammatory effect in rat models of inflammation. Eur J Pharmacol 415: 85–94.
McCulloch J, Komjati K, Valeriani V, Dewar D. 2002. Beyond neuroprotection: The protection of axons and oligodendrocytes in cerebral ischemia. Cerebrovascular Disease, 22nd Princeton Conference. Pak Chan, editor. Cambridge: Cambridge University Press; pp. 404–415.
McNerney R, Tavasolli M, Shall S, Brazinski A, Johnstone A. 1989. Changes in mRNA levels of poly(ADP-ribose) polymerase during activation of human lymphocytes. Biochem Biophys Acta 1009: 185–187.
Meli E, Pangallo M, Picca R, Baronti R, Moroni F, et al. 2004. Differential role of poly(ADP-ribose) polymerase-1 in apoptotic and necrotic neuronal death induced by mild or intense NMDA exposure in vitro. Mol Cell Neurosci 25: 172–180.
Menissier-de Murcia J, Niedergang C, Trucco C, Ricoul M, Dutrillaux B, et al. 1997. Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells. Proc Natl Acad Sci USA 94: 7303–7307.
Merrill JE, Ignarro LJ, Sherman MP, Melinek J, Lane TE. 1993. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol 151: 2132–2141.
Mésenge C, Charriaut-Marlangue C, Verrecchia C, Allix M, Boulu RG, et al. 1998a. Reduction of tyrosine nitration after N ω-nitro-l-arginine-methylester treatment of mice with traumatic brain injury. Eur J Pharmacol 353: 53–57.
Mésenge C, Margaill I, Verrecchia C, Allix M, Boulu RG, et al. 1998b. Protective effect of melatonin in a model of traumatic brain injury in mice. J Pineal Res 25: 41–46.
Mésenge C, Verrecchia C, Allix M, Boulu RG, Plotkine M. 1996. Reduction of the neurological deficit in mice with traumatic brain injury by nitric oxide synthase inhibitors. J Neurotrauma 13: 209–214.
Mésenge C, Verrecchia C, Charriaut- Marlangue C, Boulu RG, Plotkine MJ. 1999. Peroxynitrite-PARS pathway activation following traumatic brain injury in mice. J Cereb Blood Flow Metab 19: S390.
Mikawa S, Kinouchi H, Kamii H, Gobbel GT, Chen SF, et al. 1996. Attenuation of acute and chronic damage following traumatic brain injury in copper, zinc-superoxide dismutase transgenic mice. J Neurosurg 85: 885–891.
Minchenko AG, Stevens MJ, White L, Abatan OI, Komjáti K, et al. 2003. Diabetes-induced overexpression of endothelin-1 and endothelin receptors in the rat renal cortex is mediated via poly(ADP-ribose) polymerase activation. FASEB J 17: 1514–1516.
Mitrovic B, Ignarro LJ, Montestruque S, Smoll A, Merrill JE. 1994a. Nitric oxide as a potential pathological mechanism in demyelination: Its differential effects on primary glial cells in vitro. Neuroscience 61: 575–585.
Mitrovic B, Ignarro LJ, Vinters HV, Akers M-A, Schmid I, et al. 1995. Nitric oxide induces necrotic but not apoptotic cell death in oligodendrocytes. Neuroscience 65: 531–539.
Mitrovic B, Parkinson J, Merrill JE. 1996. An in vitro model of oligodendrocyte destruction by nitric oxide and its relevance to multiple sclerosis. Methods 10: 501–513.
Mitrovic B, St. Pierre BA, Mackenzie-Graham AJ, Merrill JE. 1994b. The role of nitric oxide in glial pathology. Ann NY Acad Sci 738: 436–446.
Mokudai T, Ayoub IA, Sakakibara Y, Lee EJ, Ogilvy CS, et al. 2000. Delayed treatment with nicotinamide (vitamin B 3) improves neurological outcome and reduces infarct volume after transient focal cerebral ischemia in Wistar rats. Stroke 31: 1679–1685.
Moroni F, Meli E, Peruginelli F, Chiarugi A, Cozzi A, et al. 2001. Poly(ADP-ribose) polymerase inhibitors attenuate necrotic but not apoptotic neuronal death in experimental models of cerebral ischemia. Cell Death Differ 8: 921–932.
Muralikrishna Rao A, Dogan A, Hatcher JF, Dempsey RJ. 1998. Fluorometric assay of nitrite and nitrate in brain tissue after traumatic brain injury and cerebral ischemia. Brain Res 793: 265–270.
Nag S, Picard P, Stewart DJ. 2001. Expression of nitric oxide synthases and nitrotyrosine during blood–brain barrier breakdown and repair after cold injury. Lab Invest 81: 41–49.
Nagayama T, Simon RP, Chen D, Henshall DC, Pei W, et al. 2000. Activation of poly(ADP-ribose) polymerase in the rat hippocampus may contribute to cellular recovery following sublethal transient global ischemia. J Neurochem 74: 1636–1645.
Nakahara S, Yone K, Setoguchi T, Yamaura I, Arishima Y, et al. 2002. Changes in nitric oxide and expression of nitric oxide synthase in spinal cord after acute traumatic injury in rats. J Neurotrauma 19: 1467–1474.
Nakajima H, Kakui N, Ohkuma K, Ishikawa M, Hasegawa T. 2005. A newly synthesized poly(ADP-ribose) polymerase inhibitor, 2-methyl-3,5,7,8-tetrahydrothiopyrano[4,3-d]pyrimidine-4-one (DR2313): Pharmacological profiles, neuroprotective effects, and therapeutic time window in cerebral ischemia in rats. J Pharmacol Exp Ther 312: 472–481.
Neumann H. 2003. Molecular mechanisms of axonal damage in inflammatory central nervous system diseases. Curr Opin Neurol 16: 267–273.
Nishio S, Yunoki M, Noguchi Y, Kawauchi M, Asari S, et al. 1997. Detection of lipid peroxidation and hydroxyl radicals in brain contusion of rats. Acta Neurochir Suppl (Wien) 70: 84–86.
Nucci C, Piccirilli S, Rodino P, Nistico R, Grandinetti M, et al. 2001. Apoptosis in the dorsal lateral geniculate nucleus after monocular deprivation involves glutamate signaling, NO production, and PARP activation. Biochem Biophys Res Commun 278: 360–367.
Oei SL, Ziegler M. 2000. ATP for the DNA ligation step in base excision repair is generated from poly(ADP-ribose). J Biol Chem 275: 23234–23239.
Oikawa A, Tohda H, Kanai M, Miwa M, Sugimura T. 1980. Inhibitors of poly(adenosine diphosphate-ribose) polymerase induce sister chromatid exchanges. Biochem Biophys Res Commun 97: 1311–1316.
Oka M, Hirouchi M, Itoh Y, Ukai Y. 2000. Involvement of peroxynitrite and hydroxyradical generated from nitric oxide in hypoxia/reoxygenation injury in rat cerebrocortical slices. Neuropharmacology 39: 1319–1330.
Oldendorf WH, Cornford ME, Brown WJ. 1977. The large apparent work capability of the blood–brain barrier: A study of the mitochondrial content of capillary endothelial cells in brain and other tissues of the rat. Ann Neurol 1: 409–417.
Oliver FJ, Menissier-de Murcia J, Nacci C, Decker P, Andriantsitohaina R, et al. 1999. Resistance to endotoxic shock as a consequence of defective NF-κB activation in poly(ADP-ribose) polymerase-1-deficient mice. EMBO J 18: 4446–4454.
Osborne KA, Shigeno T, Balarsky AM, Ford I, McCulloch J, et al. 1987. Quantitative assessment of early brain damage in a rat model of focal cerebral ischemia. J Neurol Neurosurg Psychiatry 50: 402–410.
Pacher P, Cziraki A, Mabley JG, Liaudet L, Papp L, et al. 2002a. Role of poly(ADP-ribose) polymerase activation in endotoxin-induced cardiac collapse in rodents. Biochem Pharmacol 64: 1785–1791.
Pacher P, Liaudet L, Bai P, Virag L, Mabley J, et al. 2002b. Activation of poly(ADP-ribose) polymerase contributes to the development of doxorubicin-induced heart failure. J Pharmacol Exp Ther 300: 862–867.
Pacher P, Liaudet L, Mabley J, Komjati K, Szabó C. 2002c. Pharmacologic inhibition of poly(adenosine diphosphate-ribose) polymerase may represent a novel therapeutic approach in chronic heart failure. J Am Coll Cardiol 40: 1006–1016.
Pacher P, Liaudet L, Soriano FG, Mabley JG, Szabó é, et al. 2002d. The role of poly(ADP-ribose) polymerase in the development of myocardial and endothelial dysfunction in diabetes mellitus. Diabetes 51: 514–521.
Pacher P, Mabley JG, Soriano FG, Liaudet L, Komjati K, et al. 2002e. Endothelial dysfunction in aging animals: The role of poly(ADP-ribose) polymerase activation. Br J Pharmacol 135: 1347–1350.
Pacher P, Mabley JG, Soriano FG, Liaudet L, Szabó C. 2002f. Activation of poly(ADP-ribose) polymerase contributes to the endothelial dysfunction associated with hypertension and aging. Int J Mol Med 9: 659–664.
Pacher P, Vaslin A, Benko R, Mabley JG, Liaudet L, et al. 2004. A new, potent poly(ADP-ribose) polymerase inhibitor improves cardiac and vascular dysfunction associated with advanced aging. J Pharmacol Exp Ther 311: 485–491.
Park EM, Cho S, Frys K, Racchumi G, Zhou P, et al. 2004. Interaction between inducible nitric oxide synthase and poly(ADP-ribose) polymerase in focal ischemic brain injury. Stroke 35: 2896–2901.
Park SD, Kim CG, Kim MG. 1983. Inhibitors of poly(ADP-ribose) polymerase enhance DNA strand breaks, excision repair, and sister chromatid exchanges induced by alkylating agents. Environ Mutagen 5: 515–525.
Park WS, Chang YS, Lee M. 2001. 3-Aminobenzamide, a poly(ADP-ribose) synthetase inhibitor, attenuates the acute inflammatory responses and brain injury in experimental Escherichia coli meningitis in the newborn piglet. Neurol Res 23: 410–416.
Paschen W, Olah L, Mies G. 2000. Effect of transient focal ischemia of mouse brain on energy state and NAD levels: No evidence that NAD depletion plays a major role in secondary disturbances of energy metabolism. J Neurochem 75: 1675–1680.
Payan HM, Conrad JR. 1977. Carotid ligation in gerbils. Influence of age, sex, and gonads. Stroke 8: 194–196.
Pearse DD, Chatzipanteli K, Marcillo AE, Bunge MB, Dietrich WD. 2003. Comparison of iNOS inhibition by antisense and pharmacological inhibitors after spinal cord injury. J Neuropathol Exp Neurol 62: 1096–1107.
Pedchenko TV, LeVine SM. 1998. Desferrioxamine suppresses experimental allergic encephalomyelitis induced by MBP in SJL mice. J Neuroimmunol 84: 188–197.
Petty MA, Poulet P, Haas A, Namer IJ, Wagner J. 1996. Reduction of traumatic brain injury-induced cerebral oedema by a free radical scavenger. Eur J Pharmacol 307: 149–155.
Pfister HW, Feiden W, Einhaupl KM. 1993. Spectrum of complications during bacterial meningitis in adults. Results of a prospective clinical study. Arch Neurol 50: 575–581.
Piconi L, Quagliaro L, Da Ros R, Assaloni R, Giugliano D, et al. 2004. Intermittent high glucose enhances ICAM-1, VCAM-1, E-selectin, and interleukin-6 expression in human umbilical endothelial cells in culture: The role of poly(ADP-ribose) polymerase. J Thromb Haemost 2: 1453–1459.
Pieper AA, Brat DJ, Krug DK, Watkins CC, Gupta A, et al. 1999. Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes. Proc Natl Acad Sci USA 96: 3059–3064.
Pineda JA, Aono M, Sheng H, Lynch J, Wellons JC, et al. 2001. Extracellular superoxide dismutase overexpression improves behavioral outcome from closed head injury in the mouse. J Neurotrauma 18: 625–634.
Plaschke K, Kopitz J, Weigand MA, Martin E, Bardenheuer HJ. 2000a. The neuroprotective effect of cerebral poly(ADP-ribose) polymerase inhibition in a rat model of global ischemia. Neurosci Lett 284: 109–112.
Plaschke K, Yun SW, Martin E, Hoyer S, Bardenheuer HJ. 2000b. Linear relation between cerebral phosphocreatine concentration and memory capacities during permanent brain vessel occlusions in rats. Ann N Y Acad Sci 903: 299–306.
Poirier GG, de Murcia G, Jongstra-Bilen J, Niedergang C, Mande P. 1982. Poly(ADP-ribosylation) of polynuclesomes causes relaxation of chromatin structure. Proc Natl Acad Sci 79: 3423–3427.
Pratico D, Reiss P, Tang LX, Sung S, Rokach J, et al. 2002. Local and systemic increase in lipid peroxidation after moderate experimental traumatic brain injury. J Neurochem 80: 894–898.
Przedborski S, Jackson-Lewis V. 1998. Mechanisms of MPTP toxicity. Mov Disord 13 (Suppl 1): 35–38.
Przedborski S, Jackson-Lewis V, Yokoyama R, Shibata T, Dawson VL, et al. 1996. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc Natl Acad Sci USA 93: 4565–4571.
Prineas JW. 1975. Pathology of the early lesion in multiple sclerosis. Hum Pathol 6: 531–554.
Rink A, Fung KM, Trojanowski JQ, Lee VM, Neugebauer E, et al. 1995. Evidence of apoptotic cell death after experimental traumatic brain injury in the rat. Am J Pathol 147: 1575–1583.
Rudat V, Kupper JH, Weber KJ. 1998. Trans-dominant inhibition of poly(ADP-ribosylation) leads to decreased recovery from ionizing radiation-induced cell killing. Int J Radiat Biol 73: 325–330.
Sakakibara Y, Mitha AP, Ogilvy CS, Maynard KI. 2000. Posttreatment with nicotinamide (Vitamin B 3) reduces the infarct volume following permanent focal cerebral ischemia in female Sprague–Dawley and Wistar rats. Neurosci Lett 281: 111–114.
Sakamoto KI, Fujisawa H, Koizumi H, Tsuchida E, Ito H, et al. 1997. Effects of mild hypothermia on nitric oxide synthesis following contusion trauma in the rat. J Neurotrauma 14: 349–353.
Satchell MA, Zhang X, Kochanek PM, Dixon CE, Jenkins LW, et al. 2003. A dual role for poly(ADP-ribosylation) in spatial memory acquisition after traumatic brain injury in mice involving NAD + depletion and ribosylation of 14-3-3γ. J Neurochem 85: 697–708.
Satoh M, Date I, Nakajima M, Takahashi K, Iseda K, et al. 2001. Inhibition of poly(ADP-ribose) polymerase attenuates cerebral vasospasm after subarachnoid hemorrhage in rabbits. Stroke 32: 225–231.
Satoh MS, Lindahl T. 1992. Role of poly(ADP-ribose) formation in DNA repair. Nature 356: 356–358.
Schipper HM. 1996. Astrocytes, brain aging, and neurodegeneration. Neurobiol Aging 17: 467–480.
Schulz JB, Matthews RT, Beal MF. 1995a. Role of nitric oxide in neurodegenerative diseases. Curr Opin Neurol 8: 480–486.
Schulz JB, Matthews RT, Jenkins BG, Ferrante RJ, Siwek D, et al. 1995b. Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo. J Neurosci 15: 8419–8429.
Schulz JB, Matthews RT, Muqit MM, Browne SE, Beal MF. 1995c. Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. J Neurochem 64: 936–939.
Scott GS, Jakeman LB, Stokes BT, Szabó C. 1999. Peroxynitrite production and activation of poly(adenosine diphosphate-ribose) synthetase in spinal cord injury Ann Neurol 45: 120–124.
Scott GS, Kean RB, Mikheeva T, Fabis MJ, Mabley JG, et al. 2004. The therapeutic effects of PJ34 [N-(6-oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide.HCl], a selective inhibitor of poly(ADP-ribose) polymerase, in experimental allergic encephalomyelitis are associated with immunomodulation. J Pharmacol Exp Ther 310: 1053–1061.
Scott GS, Kean RB, Southan GJ, Szabó C, Hooper DC. 2001. Effect of mercaptoethylguanidine scavengers of peroxynitrite on the development of experimental allergic encephalomyelitis in PLSJL mice. Neurosci Lett 311: 125–128.
Scott GS, Szabó C, Hooper DC. 2004. Poly(ADP-ribose) polymerase activity contributes to peroxynitrite-induced spinal cord neuronal cell death in vitro. J Neurotrauma 21: 1255–1263.
Scott GS, Virág L, Szabó C, Hooper DC. 2003. Peroxynitrite-induced oligodendrocyte toxicity is not dependent on poly(ADP-ribose) polymerase activation. Glia 41: 105–116.
Shall S, De Murcia G. 2000. Poly(ADP-ribose) polymerase-1: What have we learned from the deficient mouse model? Mutat Res 460: 1–15.
Sharma HS, Sjoquist PO, Alm P. 2003. A new antioxidant compound H-290151 attenuates spinal cord injury-induced expression of constitutive and inducible isoforms of nitric oxide synthase and edema formation in the rat. Acta Neurochir (Suppl 86): 415–420.
Sharma HS, Westman J, Olsson Y, Alm P. 1996. Involvement of nitric oxide in acute spinal cord injury: An immunocytochemical study using light and electron microscopy in the rat. Neurosci Res 24: 373–384.
Sharma SS, Munusamy S, Thiyagarajan M, Kaul CL. 2004. Neuroprotective effect of peroxynitrite decomposition catalyst and poly(adenosine diphosphate-ribose) polymerase inhibitor alone and in combination in rats with focal cerebral ischemia. J Neurosurg 101: 669–675.
Sharp C, Warren A, Oshima T, Williams L, Li JH, et al. 2001. Poly(ADP-ribose) polymerase inhibitors prevent the upregulation of ICAM-1 and E-selectin in response to T H1 cytokine stimulation. Inflammation 25: 157–163.
Shimoda K, Murakami K, Enkhbaatar P, Traber LD, Cox RA, et al. 2003. Effect of poly(ADP-ribose) synthetase inhibition on burn and smoke inhalation injury in sheep. Am J Physiol Lung Cell Mol Physiol 285: L240–L249.
Shohami E, Gati I, Beit-Yannai E, Trembovler, V, Kohen, R. 1999. Closed head injury in the rat induces whole body oxidative stress: Overall reducing antioxidant profile. J Neurotrauma 16: 365–376.
Simbulan-Rosenthal CM, Ly DH, Rosenthal DS, Konopka G, Luo R, et al. 2000. Misregulation of gene expression in primary fibroblasts lacking poly(ADP-ribose) polymerase. Proc Natl Acad Sci USA 97: 11274–11279.
Simbulan-Rosenthal CM, Rosenthal DS, Luo R, Li JH, Zhang, J. et al. 2001. Inhibition of poly(ADP-ribose) polymerase activity is insufficient to induce tetraploidy. Nucleic Acids Res 29: 841–849.
Skakakibara Y, Mitha AP, Ayoub IA, Ogilvy CS, Maynard, KI. 2002. Delayed treatment with nicotinamide (vitamin B 3) reduces the infarct volume following focal cerebral ischemia in spontaneously hypertensive rats, diabetic and nondiabetic Fischer 344 rats. Brain Res 931: 68–73.
Skaper SD. 2003. Poly(ADP-ribose) polymerase-1 in acute neuronal death and inflammation. Ann N Y Acad Sci 993: 217–228.
Snyder SH. 1996. No NO prevents Parkinsonism. Nat Med 2: 965–966.
Sobel R. 1995. The pathology of multiple sclerosis. Neurol Clin 13: 1–21.
Sonee M, Martens JR, Mukherjee SK. 2002. Nicotinamide protects HCN2 cells from the free radical generating toxin, tertiary butylhydroperoxide (t-BuOOH). Neurotox Res 2002 4: 595–599.
Soriano FG, Liaudet L, Szabó E, Virag L, Mabley JG, et al. 2002. Resistance to acute septic peritonitis in poly(ADP-ribose) polymerase-1-deficient mice. Shock 17: 286–292.
Soriano FG, Mabley JG, Pacher P, Liaudet L, Szabó C. 2001. Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly(ADP-ribose) polymerase. Circ Res 89: 684–691.
Southan GJ, Szabó C. 2003. Poly(ADP-ribose) polymerase inhibitors. Curr Med Chem 10: 321–340.
STAIR II. 2001. Recommendations for clinical trial evaluation of acute stroke therapies. Stroke 32: 1598–1606.
Stein DG. 2001. Brain damage, sex hormones, and recovery: A new role for progesterone and estrogen? Trends Neurosci 24: 386–391.
Stroke Therapy Academic Industry Roundtable (STAIR) 1999. Recommendations for standards regarding preclinical neuroprotective and restorative drugs. Stroke 30: 2752–2758.
Sugawara T, Lewen A, Gasche Y, Yu F, Chan, PH. 2002. Overexpression of SOD1 protects vulnerable motor neurons after spinal cord injury by attenuating mitochondrial cytochrome c release FASEB J 16: 1997–1999.
Suh SW, Aoyama K, Chen Y, Garnier P, Matsumori Y, et al. 2003. Hypoglycemic neuronal death and cognitive impairment are prevented by poly(ADP-ribose) polymerase inhibitors administered after hypoglycemia. J Neurosci 23: 10681–10690.
Suzuki T, Tatsuoka H, Chiba T, Sekikawa T, Nemoto T, et al. 2001. Beneficial effects of nitric oxide synthase inhibition on the recovery of neurological function after spinal cord injury in rats. Naunyn Schmiedebergs Arch Pharmacol 363: 94–100.
Szabó C. 1996. DNA strand breakage and activation of poly(ADP ribosyltransferase): A cytotoxic pathway triggered by peroxynitrite. Free Radic Biol Med 21: 855–869.
Szabó C. 2000. Cell death: The role of PARP. Boca Raton, Florida, USA: CRC Press.
Szabó C. 2003a. Nicotinamide: A jack of all trades (but master of none?). Intensive Care Med 29(6): 863–866.
Szabó C. 2003b. Multiple pathways of peroxynitrite cytotoxicity. Toxicol Lett 140-141: 105–112.
Szabó C, Dawson VL. 1998. Role of poly(ADP-ribose) synthetase activation in inflammation and reperfusion injury. Trends Pharmacol Sci 19: 287–298.
Szabó C, Cuzzocrea S, Zingarelli B, O'Connor M, Salzman AL. 1997a. Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly(ADP-ribose) synthetase by peroxynitrite. J Clin Invest 100: 723–735.
Szabó C, Lim LH, Cuzzocrea S, Getting SJ, Zingarelli B, et al. 1997b. Inhibition of poly(ADP-ribose) synthetase attenuates neutrophil recruitment and exerts antiinflammatory effects. J Exp Med 186: 1041–1049.
Szabó C, Pacher P, Zsengeller Z, Vaslin A, Komjati K, et al. 2004. Angiotensin II-mediated endothelial dysfunction: Role of poly(ADP-ribose) polymerase activation. Mol Med 2004 10: 28–35.
Szabó C, Virág L, Cuzzocrea S, Scott GJ, Hake P, et al. 1998. Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthetase. Proc Natl Acad Sci USA 95: 3867–3872.
Szabó C, Zanchi A, Komjati K, Pacher P, Krolewski AS, et al. 2002b. Poly(ADP-ribose) polymerase is activated in subjects at risk of developing type 2 diabetes and is associated with impaired vascular reactivity. Circulation 106: 2680–2686.
Szabó C, Zingarelli B, O'Connor M, Salzman AL. 1996. DNA strand breakage, activation of poly (ADP ribosyl) synthetase, and cellular energy depletion are involved in the cytotoxicity in macrophages and smooth muscle cells exposed to peroxynitrite. Proc Natl Acad Sci USA 93: 1753–1758.
Szabó E, Kern TS, Virag L, Mabley J, Szabó C. 2001. Evidence for poly(ADP-ribose) polymerase activation in the diabetic retina. FASEB J 15: A942.
Szabó G, Bährle S, Stumpf N, Sonnenberg K, Szabó E, et al. 2002a. Poly(ADP-ribose) polymerase inhibition reduces reperfusion injury after heart transplantation. Circ Res 90: 100–106.
Tabuchi K, Ito Z, Tsuji S, Nakagawa A, Serizawa F, et al. 2001. Poly(adenosine diphosphate-Ribose) synthetase inhibitor 3-aminobenzamide alleviates cochlear dysfunction induced by transient ischemia. Ann Otol Rhinol Laryngol 110: 118–121.
Takahashi K, Greenberg JH, Jackson P, Maclin K, Zhang J. 1997. Neuroprotective effects of inhibiting poly(ADP-ribose) synthetase on focal cerebral ischemia in rats. J Cereb Blood Flow Metab 17: 1137–1142.
Takahashi K, Pieper AA, Croul SE, Zhang J, Snyder SH, et al. 1999. Posttreatment with an inhibitor of poly(ADP-ribose) polymerase attenuates cerebral damage in focal ischemia. Brain Res 829: 46–54.
Takahashi G, Sakurai M, Abe K, Itoyama Y, Tabayashi K. 2003. MCI-186 prevents spinal cord damage and affects enzyme levels of nitric oxide synthase and Cu/Zn superoxide dismutase after transient ischemia in rabbits. J Thorac Cardiovasc Surg 126: 1461–1466.
Tanaka J, Toku K, Zhang B, Ishihara K, Sakanaka M. et al. 1999. Astrocytes prevent neuronal death induced by reactive oxygen and nitrogen species. Glia 28: 85–96.
Tasker RC, Sahota SK, Cotter, FE, Williams, SR. 1998. Early postischemic dantrolene-induced amelioration of poly(ADP-ribose) polymerase-related bioenergetic failure in neonatal rat brain slices. J Cereb Blood Flow Metab 18: 1346–1356.
Tentori L, Portarena I, Graziani G. 2002. Potential clinical applications of poly(ADP-ribose) polymerase (PARP) inhibitors. Pharmacol Res 45: 73–85.
Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, et al. 1995. Yama/CPP32 β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81: 801–809.
The National Institute of Neurological Disorders and Stroke rtPA Stroke Study Group 1995. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333: 1581–1587.
Tokime T, Nozaki K, Sugino T, Kikuchi H, Hashimoto N, et al. 1998. Enhanced poly(ADP-ribosylation) after focal ischemia in rat brain. J Cereb Blood Flow Metab 18: 991–997.
Touil T, Deloire-Grassin MS, Vital C, Petry KG, Brochet B. 2001. In vivo damage of CNS myelin and axons induced by peroxynitrite. NeuroReport 12: 3637–3644.
Tyurin VA, Tyurina YY, Borisenko GG, Sokolova TV, Ritov VB, et al. 2000. Oxidative stress following traumatic brain injury in rats: Quantitation of biomarkers and detection of free radical intermediates. J Neurochem 75: 2178–2189.
Ullrich O, Ciftci O, Hass R. 2000. Proteasome activation by poly(ADP-ribose) polymerase in human myelomonocytic cells after oxidative stress. Free Radic Biol Med 29: 995–1004.
Ullrich O, Diestel A, Eyupoglu IY, Nitsch R. 2001. Regulation of microglial expression of integrins by poly(ADP-ribose) polymerase-1. Nat Cell Biol 3: 1035–1042.
Ullrich O, Reinheckel T, Sitte N, Hass R, Grune, T, et al. 1999. Poly(ADP ribose) polymerase activates nuclear proteasome to degrade oxidatively damaged histones. Proc Natl Acad Sci USA 96: 6223–6228.
Van der Veen RC, Hinton DR, Incardonna F, Hofman FM. 1997. Extensive peroxynitrite activity during progressive stages of central nervous system inflammation. J Neuroimmunol 77: 1–7.
Vaziri ND, Lee YS, Lin CY, Lin VW, Sindhu RK. 2004. NAD(P)H oxidase, superoxide dismutase, catalase, glutathione peroxidase, and nitric oxide synthase expression in subacute spinal cord injury. Brain Res 995: 76–83.
Virag, L, Szabó C. 2002. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev 54: 375–429.
Virag L, Scott GS, Antal-Szalmas P, O'Connor M, Ohshima H, et al. 1999. Requirement of intracellular calcium mobilization for peroxynitrite-induced poly(ADP-ribose) synthetase activation and cytotoxicity. Mol Pharmacol 56: 824–833.
Vispé S, Yung TMC, Ritchot J, Serizawa H, Satoh MS. 2000. A cellular defense pathway regulating transcription through poly(ADP-ribosylation) in response to DNA damage. Proc Natl Acad Sci USA 97: 9886–9891.
Wallis RA, Panizzon KL, Girard JM. 1996. Traumatic neuroprotection with inhibitors of nitric oxide and ADP-ribosylation. Brain Res 710: 169–177.
Wallis RA, Panizzon KL, Henry D, Wasterlain CG. 1993. Neuroprotection against nitric oxide injury with inhibitors of ADP-ribosylation. Neuroreport 5: 245–248.
Wang H, Shimoji M, Yu SW, Dawson TM, Dawson VL. 2003. Apoptosis-inducing factor and PARP-mediated injury in the MPTP mouse model of Parkinson's disease. Ann N Y Acad Sci 991: 132–139.
Weltin D, Picard K, Aupeix K, Varin M, Oth D, et al. 1995. Immunosuppressive activities of 6(5H)-phenanthridinone, a new poly(ADP-ribose) polymerase inhibitor. Int J Immunopharmacol 17: 265–271.
Whalen MJ, Clark RS, Dixon CE, Robichaud P, Marion DW, et al. 1999. Reduction of cognitive and motor deficits after traumatic brain injury in mice deficient in poly(ADP-ribose) polymerase. J Cereb Blood Flow Metab 19: 835–842.
Wiley CA, Achim CL, Hammond R, Love S, Masliah E, et al. 2000. Damage and repair of DNA in HIV encephalitis. J Neuropathol Exp Neurol 2000 59: 955–965.
Williams L, Liang S, Lautar S, 1999. GPI-6150, a potent PARP inhibitor reduces infarct size following permanent and transient focal cerebral ischemia. Soc Neurosci 25: 1061 [Abstract].
Wu W, Liuzzi FG, Schinco FP, Depto AS, Li Y, et al. 1994. Neuronal nitric oxide synthase is induced in spinal neurons by traumatic injury. Neuroscience 61: 719–726.
Wullner U, Weller M, Groscurth P, Loschmann PA, Schulz JB, et al. 1997. Evidence for an active type of cell death with ultrastructural features distinct from apoptosis: The effects of 3-acetylpyridine neurotoxicity. Neuroscience 81: 721–734.
Xu J, Kim G-M, Chen S, Yan P, Ahmed SH, et al. 2001. iNOS and nitrotyrosine expression after spinal cord injury. J Neurotrauma 18: 523–532.
Yamanaka K, Kumura E, Iwatsuki K, Yoshimine T, Masana Y, et al. 1995. Increase in plasma nitric oxide end products following rat cortical injury. Neurosci Lett 194: 124–126.
Yang JC, Cortopassi GA. 1998. Induction of mitochondrial permeability transition causes release of the apoptogenic factor cytochrome c. Free Radic Biol Med 24: 624–631.
Yang J, He L, Wang J Adams JD Jr. 2004. Early administration of nicotinamide prevents learning and memory impairment in mice induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Pharmacol Biochem Behav 78: 179–183.
Yang J, Klaidman LK, Chang ML, Kem L, Sugawara T, et al. 2002. Nictonamide therapy protects against both neurosis and apoptosis in a stroke model. Pharmacol Biochem Behav 73(4): 901–910.
Ying W, Swanson RA. 2000. The poly(ADP-ribose) glycohydrolase inhibitor gallotannin blocks oxidative astrocyte death. Neuroreport 11: 1385–1388.
Ying W, Chen Y, Alano CC, Swanson RA. 2002. Tricarboxylic acid cycle substrates prevent PARP-mediated death of neurons and astrocytes. J Cereb Blood Flow Metab. 22: 774–779.
Ying W, Garnier P, Swanson RA. 2003. NAD + repletion prevents PARP-1-induced glycolytic blockade and cell death in cultured mouse astrocytes. Biochem Biophys Res Commun 308: 809–8013.
Ying W, Sevigny MB, Chen Y, Swanson RA. 2001. Poly(ADP-ribose) glycohydrolase mediates oxidative and excitotoxic neuronal death. Proc Natl Acad Sci USA 98: 12227–12232.
Yu SW, Wang H, Poitras MF, Coombs C, Bowers WJ, et al. 2002. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 297: 259–263.
Yune TY, Chang MJ, Kim SJ, Lee YB, Shin SW, et al. 2003. Increased production of tumor necrosis factor-α induces apoptosis after traumatic spinal cord injury in rats. J Neurotrauma 20: 207–219.
Zhang C, Yang J, Jennings LK. 2004. Attenuation of neointima formation through the inhibition of DNA repair enzyme PARP-1 in balloon-injured rat carotid artery. Am J Physiol Heart Circ Physiol 287: H659–H666.
Zhang J. 2002. Therapeutic implications of PARP inhibition. Boca Raton, Florida: CRC Press.
Zhang J, Dawson VL, Dawson, TM, Snyder SH. 1994. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science 263: 687–689.
Zhang J, Pieper A, Snyder SH. 1995. Poly(ADP-ribose) synthetase activation: An early indicator of neurotoxic DNA damage. J Neurochem 65: 1411–1414.
Zhang, Y, Rosenberg PA. 2004. Caspase-1 and poly(ADP-ribose) polymerase inhibitors may protect against peroxynitrite-induced neurotoxicity independent of their enzyme inhibitor activity. Eur J Neurosci 20: 1727–1736.
Zhang Z, Krebs CJ, Guth L. 1997. Experimental analysis of progressive necrosis after spinal cord trauma in the rat: Etiological role of the inflammatory response. Exp Neurol 143: 141–152.
Zingarelli B, Cuzzocrea S, Zsengeller Z, Salzman AL, Szabó, C. 1997. Protection against myocardial ischemia and reperfusion injury by 3-aminobenzamide, an inhibitor of poly(ADP-ribose) synthetase. Cardiovasc Res 36: 205–215.
Zingarelli B, Hake PW, O'Connor M, Denenberg A, Wong HR, et al. 2004. Differential regulation of activator protein-1 and heat shock factor-1 in myocardial ischemia and reperfusion injury: Role of poly(ADP-ribose) polymerase-1. Am J Physiol Heart Circ Physiol 286: H1408–H1415.
Zingarelli B, O'Connor M, Hake PW. 2003. Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways in colitis. Eur J Pharmacol 469: 183–194.
Zingarelli B, O'Connor M, Wong H, Salzman AL, Szabó C. 1996. Peroxynitrite-mediated DNA strand breakage activates poly(ADP ribosyl) synthetase and causes cellular energy depletion in macrophages stimulated with bacterial lipopolysaccharide. J Immunol 156: 350–358.
Zingarelli B, Salzman AL, Szabó C. 1998. Genetic disruption of poly(ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia-reperfusion injury. Circ Res 83: 85–94.
Zingarelli B, Szabó C, Salzman AL. 1999. Blockade of poly(ADP-ribose) synthetase inhibits neutrophil recruitment, oxidant generation, and mucosal injury in murine colitis. Gastroenterology 116: 335–345.
Acknowledgments
The work in the authors’ laboratories is supported by grants from the National Institutes of Health and the Hungarian Ministry of Health.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this entry
Cite this entry
Scott, G.S., Komjáti, K., Besson, V.C., Szabó, C. (2008). Role of Poly(ADP-ribose) Polymerase in Brain Inflammation and Neuroinjury. In: Lajtha, A., Galoyan, A., Besedovsky, H.O. (eds) Handbook of Neurochemistry and Molecular Neurobiology. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-30398-7_20
Download citation
DOI: https://doi.org/10.1007/978-0-387-30398-7_20
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-30358-1
Online ISBN: 978-0-387-30398-7
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences